Ofatumumab Modulates Inflammatory T Cell Responses and Migratory Potential in Patients With Multiple Sclerosis

BACKGROUND AND OBJECTIVES: The anti-CD20 antibody ofatumumab is an efficacious therapy for multiple sclerosis (MS) through depletion of B cells. The purpose of this study was to examine the derivative effects of B cell depletion on the peripheral immune system and a direct treatment effect on T cell...

Descripción completa

Detalles Bibliográficos
Autores principales: von Essen, Marina Rode, Hansen, Rikke Holm, Højgaard, Camilla, Ammitzbøll, Cecilie, Wiendl, Heinz, Sellebjerg, Finn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272791/
https://www.ncbi.nlm.nih.gov/pubmed/35672145
http://dx.doi.org/10.1212/NXI.0000000000200004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272791/
https://www.ncbi.nlm.nih.gov/pubmed/35672145
http://dx.doi.org/10.1212/NXI.0000000000200004

Ejemplares similares